Swallowable sampling device combined with methylation biomarker panel IDs Barrett esophagus. The approvals are based on data from the phase 3 CheckMate-648 trial, which included 970 adults with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback